← Leaderboards
Massimo M. Trucco
Children'S Hosp Pittsburgh/Upmc Hlth Sys
$5,161,944
Attributed
$5,161,944
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–07$2M$1.5M$1M$500K$0
'05
'06
'07
Funding mix
By agency
NIH$5,161,944 · 4
By mechanism
U19$3,287,627 · 1
R33$1,017,317 · 1
R21$571,333 · 1
R01$285,667 · 1
Top collaborators
No co-investigators on record.
Most similar at Children'S Hosp Pittsburgh/Upmc Hlth Sys
Same institution · by research overlap
- Rakesh K. Sindhi$3,236,424
- Nick Giannoukakis$3,549,775
Others in their field
Top investigators on “Autoimmunity”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$303,553,812
- Barton F Haynes · Duke University$175,178,961
- Jeffrey P Krischer · University Of South Florida$145,926,425
- Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason$84,342,024
- Mark S Anderson · University Of California, San Francisco$69,470,335
- Robert S Negrin · Stanford University$48,464,292
Research focus
AutoimmunityNod MouseClinical ResearchDisease /Disorder Prevention /ControlDisease /Disorder OnsetDendritic CellsInsulin Dependent Diabetes MellitusTissue /Cell CultureHuman SubjectBioimaging /Biomedical ImagingGreen Fluorescent ProteinsBioluminescenceBiotechnologyBlood GlucoseHuman TissueGenetically Modified AnimalsGenetic ManipulationArtificial ImmunosuppressionCell LineDeoxyribonucleotidesFluorescence MicroscopyGene TargetingCooperative StudyCd40 Molecule
Grant awards (11)
Humoral And Cellular Tolerization Approaches Against Autoimmunity$725,721
U19 · FY2007 · AI · contact PI
Humoral And Cellular Tolerization Approaches Against Au*$739,244
U19 · FY2006 · AI · contact PI
Gene-engineered dendritic cell therapy for diabetics$546,841
R33 · FY2006 · DK · contact PI
Humoral And Cellular Tolerization Approaches Against Au*$748,940
U19 · FY2005 · AI
Gene-engineered dendritic cell therapy for diabetics$470,476
R33 · FY2005 · DK
Humoral And Cellular Tolerization Approaches Against Au*$705,866
U19 · FY2004 · AI
Humoral And Cellular Tolerization Approaches Against Au*$367,856
U19 · FY2003 · AI
Gene-engineered dendritic cell therapy for diabetics$286,083
R21 · FY2003 · DK
Optical Imaging of Beta-Cell Function and Engraftment$143,083
R01 · FY2003 · DK
Gene-engineered dendritic cell therapy for diabetics$285,250
R21 · FY2002 · DK
Optical Imaging of Beta-Cell Function and Engraftment$142,584
R01 · FY2002 · DK